# OnCo record hyperglycaemia (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/hyperglycaemia/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "hyperglycaemia" ;
  schema:name "Hyperglycaemia (PI3K/AKT inhibitor class effect)"@en ;
  schema:alternateName "hyperglycemia"@en, "high blood sugar"@en, "raised glucose"@en, "glucose monitoring"@en, "PI3K inhibitor toxicity"@en, "PI3Kα inhibitor"@en, "metformin prophylaxis"@en, "SGLT2 inhibitor"@en, "ketogenic diet with PI3K inhibitors"@en ;
  schema:description "High blood sugar as a side effect of drugs that block the PI3K/AKT pathway, because the same pathway carries insulin's signal in muscle and liver. It is the main reason these otherwise effective breast cancer drugs are hard to give."@en ;
  schema:url <https://onco.cc/terms/hyperglycaemia/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Hyperglycemia> ;
  schema:citation <https://en.wikipedia.org/wiki/Hyperglycemia> ;
  onco:related <https://onco.cc/terms/therapeutic-index/>, <https://onco.cc/terms/dose-modification/>, <https://onco.cc/terms/endocrine-resistance/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/alpelisib/>, <https://onco.cc/drugs/capivasertib/> .